OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 01, 2012
The authors highlight costs, benefits, and implementation success factors across first, second, and third generations of facility management outsourcing contracts.
AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly.
Annual survey shows strong growth for service providers and promises to continue into 2013.
July 02, 2012
Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.
The past three decades have driven a purchasing evolution to a procurement revolution.
A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.
Taking time to appreciate the industry's greatest achievements will inspire growth ahead.
Companies roll out expansions in manufacturing high-potency APIs and finished products.
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
Presidents of leading associations offer views on the industry's future.